Cargando…

Propofol sparing effect of dexmedetomidine and magnesium sulfate during BIS targeted anesthesia: A prospective, randomized, placebo controlled trial

BACKGROUND AND AIMS: Maintenance of adequate depth of anesthetic is crucial to prevent awareness and to reduce stress response associated with surgery. Goals of balanced general anesthetic are met by use of adjuvants to facilitate use of lower anesthetic dose, while ensuring adequate anesthetic dept...

Descripción completa

Detalles Bibliográficos
Autores principales: Walia, Chiteshwar, Gupta, Ruchi, Kaur, Manjot, Mahajan, Lakshmi, Kaur, Gaganjot, Kaur, Bhanupreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194833/
https://www.ncbi.nlm.nih.gov/pubmed/30386016
http://dx.doi.org/10.4103/joacp.JOACP_297_17
_version_ 1783364307128418304
author Walia, Chiteshwar
Gupta, Ruchi
Kaur, Manjot
Mahajan, Lakshmi
Kaur, Gaganjot
Kaur, Bhanupreet
author_facet Walia, Chiteshwar
Gupta, Ruchi
Kaur, Manjot
Mahajan, Lakshmi
Kaur, Gaganjot
Kaur, Bhanupreet
author_sort Walia, Chiteshwar
collection PubMed
description BACKGROUND AND AIMS: Maintenance of adequate depth of anesthetic is crucial to prevent awareness and to reduce stress response associated with surgery. Goals of balanced general anesthetic are met by use of adjuvants to facilitate use of lower anesthetic dose, while ensuring adequate anesthetic depth. This study employed BIS monitoring to compare the anesthetic sparing effects of intravenous dexmedetomidine and magnesium sulphate on induction dose of propofol by maintaining a BIS value of 40-50. MATERIAL AND METHODS: One hundred and twenty ASA I and II patients undergoing elective surgery under general anesthetic were included in three groups of forty each. Group D received 1 μg/kg of dexmedetomidine, Group M was given 30 mg/kg of magnesium sulphate in 100 ml saline and Group N received 100 ml saline over 15-20 minutes 15 minutes before induction. Data compared were dose of propofol and vecuronium, Ramsay sedation score, BIS values and hemodynamic parameters intraoperatively. RESULTS: Propofol required in group D was significantly lower 101.3 ± 16.5 than group M and N with dose of 114 ± 15.5 and 160.50 ± 25.08 respectively (p <0.001). Dose requirement of vecuronium was significantly reduced in group M 5.4 ± 0.8 and group D 6.6 ± 1.2 as compared to N 7.9 ± 1.4 (p <0.001). No significant differences were seen regarding baseline hemodynamics, RSS and BIS values in all groups. After study drug infusion, RSS was 4.59 ± 0.75 in dexmedetomidine group compared to 1.9 ± 0.7 and 1.4 ± 0.5 in group M and N (p <0.001). During maintenance, significantly lower HR, MAP and BIS values were seen in group D and M than N (p <0.001). CONCLUSION: Our study showed that pretreatment with dexmedetomidine and magnesium sulphate significantly reduced the induction dose of propofol by maintaining a constant BIS in value at 40-50. However, both the drugs reduced the time to reach BIS 40-50 but sedation and sparing of propofol was more in dexmedetomidine group.
format Online
Article
Text
id pubmed-6194833
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-61948332018-10-31 Propofol sparing effect of dexmedetomidine and magnesium sulfate during BIS targeted anesthesia: A prospective, randomized, placebo controlled trial Walia, Chiteshwar Gupta, Ruchi Kaur, Manjot Mahajan, Lakshmi Kaur, Gaganjot Kaur, Bhanupreet J Anaesthesiol Clin Pharmacol Original Article BACKGROUND AND AIMS: Maintenance of adequate depth of anesthetic is crucial to prevent awareness and to reduce stress response associated with surgery. Goals of balanced general anesthetic are met by use of adjuvants to facilitate use of lower anesthetic dose, while ensuring adequate anesthetic depth. This study employed BIS monitoring to compare the anesthetic sparing effects of intravenous dexmedetomidine and magnesium sulphate on induction dose of propofol by maintaining a BIS value of 40-50. MATERIAL AND METHODS: One hundred and twenty ASA I and II patients undergoing elective surgery under general anesthetic were included in three groups of forty each. Group D received 1 μg/kg of dexmedetomidine, Group M was given 30 mg/kg of magnesium sulphate in 100 ml saline and Group N received 100 ml saline over 15-20 minutes 15 minutes before induction. Data compared were dose of propofol and vecuronium, Ramsay sedation score, BIS values and hemodynamic parameters intraoperatively. RESULTS: Propofol required in group D was significantly lower 101.3 ± 16.5 than group M and N with dose of 114 ± 15.5 and 160.50 ± 25.08 respectively (p <0.001). Dose requirement of vecuronium was significantly reduced in group M 5.4 ± 0.8 and group D 6.6 ± 1.2 as compared to N 7.9 ± 1.4 (p <0.001). No significant differences were seen regarding baseline hemodynamics, RSS and BIS values in all groups. After study drug infusion, RSS was 4.59 ± 0.75 in dexmedetomidine group compared to 1.9 ± 0.7 and 1.4 ± 0.5 in group M and N (p <0.001). During maintenance, significantly lower HR, MAP and BIS values were seen in group D and M than N (p <0.001). CONCLUSION: Our study showed that pretreatment with dexmedetomidine and magnesium sulphate significantly reduced the induction dose of propofol by maintaining a constant BIS in value at 40-50. However, both the drugs reduced the time to reach BIS 40-50 but sedation and sparing of propofol was more in dexmedetomidine group. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6194833/ /pubmed/30386016 http://dx.doi.org/10.4103/joacp.JOACP_297_17 Text en Copyright: © 2018 Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Walia, Chiteshwar
Gupta, Ruchi
Kaur, Manjot
Mahajan, Lakshmi
Kaur, Gaganjot
Kaur, Bhanupreet
Propofol sparing effect of dexmedetomidine and magnesium sulfate during BIS targeted anesthesia: A prospective, randomized, placebo controlled trial
title Propofol sparing effect of dexmedetomidine and magnesium sulfate during BIS targeted anesthesia: A prospective, randomized, placebo controlled trial
title_full Propofol sparing effect of dexmedetomidine and magnesium sulfate during BIS targeted anesthesia: A prospective, randomized, placebo controlled trial
title_fullStr Propofol sparing effect of dexmedetomidine and magnesium sulfate during BIS targeted anesthesia: A prospective, randomized, placebo controlled trial
title_full_unstemmed Propofol sparing effect of dexmedetomidine and magnesium sulfate during BIS targeted anesthesia: A prospective, randomized, placebo controlled trial
title_short Propofol sparing effect of dexmedetomidine and magnesium sulfate during BIS targeted anesthesia: A prospective, randomized, placebo controlled trial
title_sort propofol sparing effect of dexmedetomidine and magnesium sulfate during bis targeted anesthesia: a prospective, randomized, placebo controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194833/
https://www.ncbi.nlm.nih.gov/pubmed/30386016
http://dx.doi.org/10.4103/joacp.JOACP_297_17
work_keys_str_mv AT waliachiteshwar propofolsparingeffectofdexmedetomidineandmagnesiumsulfateduringbistargetedanesthesiaaprospectiverandomizedplacebocontrolledtrial
AT guptaruchi propofolsparingeffectofdexmedetomidineandmagnesiumsulfateduringbistargetedanesthesiaaprospectiverandomizedplacebocontrolledtrial
AT kaurmanjot propofolsparingeffectofdexmedetomidineandmagnesiumsulfateduringbistargetedanesthesiaaprospectiverandomizedplacebocontrolledtrial
AT mahajanlakshmi propofolsparingeffectofdexmedetomidineandmagnesiumsulfateduringbistargetedanesthesiaaprospectiverandomizedplacebocontrolledtrial
AT kaurgaganjot propofolsparingeffectofdexmedetomidineandmagnesiumsulfateduringbistargetedanesthesiaaprospectiverandomizedplacebocontrolledtrial
AT kaurbhanupreet propofolsparingeffectofdexmedetomidineandmagnesiumsulfateduringbistargetedanesthesiaaprospectiverandomizedplacebocontrolledtrial